Cinnamic Acid

Cinnamic Acid

SCHEMBL3763443

C=CC(=O)O.O=C(O)/C=C/c1ccccc1

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.83
HDAC3 O15379 2/20 0.83
HDAC4 P56524 2/20 0.83
HDAC1 Q13547 2/20 0.83
HDAC2 Q92769 2/20 0.83
HDAC8 Q9BY41 2/20 0.83
HDAC6 Q9UBN7 2/20 0.83
TNKS O95271 1/20 0.83
HDAC7 Q8WUI4 1/20 0.83
HDAC10 Q969S8 1/20 0.83
HDAC11 Q96DB2 1/20 0.83
TNKS2 Q9H2K2 1/20 0.83
HDAC9 Q9UKV0 1/20 0.83
HDAC5 Q9UQL6 1/20 0.83
ALDH1A1 P00352 3/20 0.61
PLIN1 O60240 2/20 0.61
LMNA P02545 2/20 0.61
MAPT P10636 2/20 0.61
RECQL P46063 2/20 0.61
PLIN5 Q00G26 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cinnamic Acid SCHEMBL3763445 1.00 HCAR2 (0.83) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL4809617 0.98 HCAR2 (0.79) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL11878425 0.92 HCAR2 (0.70) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL29364616 0.91 HCAR2 (0.83) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL28063020 0.91 HCAR2 (0.83) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL3130266 0.91 HCAR2 (0.83) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL27547468 0.91 HCAR2 (0.91) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL9277970 0.91 HCAR2 (0.91) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1332 0.91 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL50466 0.91 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113698634-A Method for preparing self-adaptive forming polymer device and application 浙江大学 2021-11-26 CN disclosed
EP-3670186-A2 METHOD FOR PRODUCING LIQUID CRYSTAL ORIENTATION FILM LG Chem, Ltd. (KR) 2020-06-24 EP disclosed
US-7851575-B2 Polycyclic polymers containing pendant ion conducting moieties PROMERUS LLC (US) 2010-12-14 US disclosed
US-20090227765-A1 Monomer for making a crosslinked polymer CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-09-10 US disclosed
US-20080242750-A1 Polycyclic polymers containing pendant ion conducting moieties PROMERUS LLC 2008-10-02 US disclosed
US-7312292-B2 Polycyclic polymers containing pendant ion conducting moieties PROMERUS LLC (US) 2007-12-25 US disclosed
WO-2006043087-A1 MONOMER FOR MAKING A CROSSLINKED POLYMER CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2006-04-27 WO disclosed
US-20050019638-A1 Polycyclic polymers containing pendant ion conducting moieties SUMITOMO BAKELITE CO., LTD. (JP) 2005-01-27 US disclosed
US-4837131-A Developing method for photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 1989-06-06 US disclosed
EP-0206308-A1 Developing method for photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 1986-12-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227765-A1 Monomer for making a crosslinked polymer AR, RAD51, RAD1 HCAR2 837/4885HDAC3 1948/4885HDAC4 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.